[go: up one dir, main page]

TR200000057T2 - 6-pirolidin-2-ilpirindinler, hazırlanmaları ve terapötik uygulamaları. - Google Patents

6-pirolidin-2-ilpirindinler, hazırlanmaları ve terapötik uygulamaları.

Info

Publication number
TR200000057T2
TR200000057T2 TR2000/00057T TR200000057T TR200000057T2 TR 200000057 T2 TR200000057 T2 TR 200000057T2 TR 2000/00057 T TR2000/00057 T TR 2000/00057T TR 200000057 T TR200000057 T TR 200000057T TR 200000057 T2 TR200000057 T2 TR 200000057T2
Authority
TR
Turkey
Prior art keywords
ylpyridines
pyrrolidin
preparation
therapeutic applications
alkyl group
Prior art date
Application number
TR2000/00057T
Other languages
English (en)
Inventor
Lochead Alistair
Jegham Samir
Galli Frederic
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of TR200000057T2 publication Critical patent/TR200000057T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Genel formül (I)'e karsilik gelen bilesik olup, (Formül(I)); söz konusu formüldeki R1 bir hidrojen atomunu, bir (C1-C4) alkil grubunu veya bir fenil (C1-C4) alkil grubunu simgelemekte; R2 bir hidrojen atomunu veya bir (C1-C4) alkil grubunu simgelemekte ve R3, R4 ve R5'in her biri bir hidrojen veya halojen atomunu veya bir triflorometil, siyano, hidroksil, (C1-C6) alkil veya (C1-C6) alkoksi grubunu simgelemektedir. Terapötik uygulama.
TR2000/00057T 1997-07-09 1998-07-07 6-pirolidin-2-ilpirindinler, hazırlanmaları ve terapötik uygulamaları. TR200000057T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9708706A FR2765874B1 (fr) 1997-07-09 1997-07-09 Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
TR200000057T2 true TR200000057T2 (tr) 2000-08-21

Family

ID=9509040

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00057T TR200000057T2 (tr) 1997-07-09 1998-07-07 6-pirolidin-2-ilpirindinler, hazırlanmaları ve terapötik uygulamaları.

Country Status (21)

Country Link
US (1) US6184229B1 (tr)
EP (1) EP1000056A1 (tr)
JP (1) JP2002508004A (tr)
KR (1) KR20010021617A (tr)
CN (1) CN1262680A (tr)
AR (1) AR013192A1 (tr)
AU (1) AU8544498A (tr)
BG (1) BG104037A (tr)
BR (1) BR9811672A (tr)
CA (1) CA2295666A1 (tr)
CO (1) CO4890850A1 (tr)
EE (1) EE200000018A (tr)
FR (1) FR2765874B1 (tr)
HU (1) HUP0003856A2 (tr)
IL (1) IL133536A0 (tr)
NO (1) NO20000066L (tr)
PL (1) PL338123A1 (tr)
SK (1) SK212000A3 (tr)
TR (1) TR200000057T2 (tr)
WO (1) WO1999002517A1 (tr)
ZA (1) ZA986047B (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005126340A (ja) * 2003-10-22 2005-05-19 Kureha Chem Ind Co Ltd 置換ピリドン類の製造法、その原料化合物及びその製造方法
CA2580329C (en) 2004-09-13 2015-01-06 Chrono Therapeutics Inc. Biosynchronous transdermal drug delivery
EP1977746B8 (en) 2007-04-02 2014-09-24 Parkinson's Institute Methods and compositions for reduction of side effects of therapeutic treatments
CA2974324A1 (en) 2015-01-28 2016-08-04 Zita S. Netzel Drug delivery methods and systems
EP3565617A1 (en) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
CA3119992A1 (en) 2018-11-16 2020-05-22 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227391A (en) * 1992-04-10 1993-07-13 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5232933A (en) * 1992-05-21 1993-08-03 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
EP1000056A1 (fr) 2000-05-17
CO4890850A1 (es) 2000-02-28
CA2295666A1 (en) 1999-01-21
NO20000066L (no) 2000-03-09
FR2765874A1 (fr) 1999-01-15
AR013192A1 (es) 2000-12-13
PL338123A1 (en) 2000-09-25
CN1262680A (zh) 2000-08-09
FR2765874B1 (fr) 1999-08-13
BR9811672A (pt) 2000-09-19
WO1999002517A1 (fr) 1999-01-21
NO20000066D0 (no) 2000-01-06
JP2002508004A (ja) 2002-03-12
US6184229B1 (en) 2001-02-06
AU8544498A (en) 1999-02-08
BG104037A (en) 2001-04-30
KR20010021617A (ko) 2001-03-15
EE200000018A (et) 2000-08-15
HUP0003856A2 (hu) 2001-10-28
ZA986047B (en) 1999-02-01
SK212000A3 (en) 2000-06-12
IL133536A0 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
TR200102403T2 (tr) Piridopiranoazepin türevleri, bunların hazırlanmaları ve terapötik uygulamaları.
ES2160408T3 (es) Trifluorfenil-triazolpirimidinas fungicidas.
TW328086B (en) Biphenylamides, compositions comprising them and the preparation and use thereof
CA2247748A1 (en) Resorcinol derivatives
TR199901674T2 (tr)
ATE228133T1 (de) Fungizide trifluorophenyltriazolopyrimidine
NL1018251A1 (nl) Organometallic monoacylalkylphosphines.
TR200402577T4 (tr) Urasil bileşikleri ve bunların kullanımları
ATE80617T1 (de) Mittel zur ortsspezifischen alkylierung.
TR199901653T2 (tr) Fitalazinonlar.
ES2012646A6 (es) Un procedimiento para la preparacion de derivados de piridazinona.
DK1036074T3 (da) S-Oxid-tetrahydrothiopyran-phenyloxazolidinoner
DK0843967T3 (da) Anvendelse af beta-aminopripionsyrederivater som fungicider
TR200200070T2 (tr) Titanyum-türevli bileşikler, bunların hazırlanması ve kullanımı.
DE69833797D1 (de) Substituierte 2-benzylamino-2-phenyl-acetamidverbindungen
TR200000057T2 (tr) 6-pirolidin-2-ilpirindinler, hazırlanmaları ve terapötik uygulamaları.
TR199902115T2 (tr) 2,3- Dihidrofuro (3,2-b) piridiun türevleri, hazirlanislari ve terapide uygulanmalari.
TR200100603T2 (tr) Pirazin bileşikleri
TR199902873T2 (tr) Miyozun modülasyonu için 17 -aliloksi(tiyo)alkil-androstan türevleri.
TR200000942T2 (tr) 8-Azabisayklo(3.2.1) oktan-3-metanamin türevleri, hazırlanmaları ve terapötik uygulamaları.
NO995289L (no) Benzimidazol-derivater
NZ326675A (en) Oxazoline arthropodicides
NO910167L (no) Haarfargemiddel.
ATE223462T1 (de) Naphthalenehydrazamimide und perylenhydrazamimide
IT1255207B (it) Composizioni farmaceutuche ad attivita' antiaggregante e vasodilatatrice